06/03/2026
Have you or someone you love been told there are limited treatment options for progressive multiple sclerosis? A new study published in The Lancet found that an already-approved MS medication may help slow disability progression in people with primary progressive multiple sclerosis (PPMS). Discover how this treatment could help patients maintain mobility and independence longer.
An already-approved MS drug can significantly slow progression in people with primary progressive multiple sclerosis (PPMS), according to a new study.Patients treated with an IV infusion of ocrelizumab (Ocrevus) were less likely to have progression of their disability, researchers report i...